Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly Interest & Investment Income of $250000.0 for Q1 2026, down 16.11% year-over-year from $298000.0 in Q1 2025, and down 65.52% quarter-over-quarter from $725000.0 in Q4 2025.
Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026) Analysis & Trends
Phibro Animal Health's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $250000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 16.11% year-over-year to $250000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 45.8% YoY), while the FY2025 annual figure was $2.6 million, down 41.39% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $250000.0, down from $725000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.3 million in Q2 2024, with the low at $250000.0 in Q1 2026.
- The 4-year median for Interest & Investment Income is $782000.0 (2024), against an average of $777727.3.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income advanced 3.98% in 2024, then sank 72.15% in 2025.
- Phibro Animal Health's Interest & Investment Income stood at $1.1 million in 2023, then declined by 26.5% to $782000.0 in 2024, then fell by 7.29% to $725000.0 in 2025, then tumbled by 65.52% to $250000.0 in 2026.
- Business Quant data shows PAHC's Interest & Investment Income at $250000.0 in Q1 2026, $725000.0 in Q4 2025, and $484000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.36 Bn | 125.68 Mn | -10.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2025 | 725,000.00 |
| Sep 30, 2025 | 484,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2015 | 92,000.00 |
| Mar 31, 2015 | 60,000.00 |
| Dec 31, 2014 | 35,000.00 |
| Sep 30, 2014 | 62,000.00 |
| Jun 30, 2014 | -59,000.00 |
| Mar 31, 2014 | 66,000.00 |
| Dec 31, 2013 | 68,000.00 |
| Sep 30, 2013 | 44,000.00 |
| Jun 30, 2013 | 34,000.00 |